Genmab A/S 2022 SR
The report highlights Genmab's progress in 2022 toward its 2030 vision of transforming cancer treatment through innovative antibody therapeutics. Key achievements include the launch of its first annual Science Day to integrate patient insights and the formalization of a patient engagement strategy. The company committed to the UN Sustainable Development Goal 13 (Climate Action) and began estimating Scope 3 emissions in alignment with TCFD recommendations. Genmab maintained strong gender diversity with 51% female representation at the director level and above. Additionally, the company hosted its first Global Volunteer Day, with employees contributing over 2,000 hours to nonprofit organizations.
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2022
Type: SR
Pages: 49
Genmab A/S
The report highlights Genmab's progress in 2022 toward its 2030 vision of transforming cancer treatment through innovative antibody therapeutics. Key achievements include the launch of its first annual Science Day to integrate patient insights and the formalization of a patient engagement strategy. The company committed to the UN Sustainable Development Goal 13 (Climate Action) and began estimating Scope 3 emissions in alignment with TCFD recommendations. Genmab maintained strong gender diversity with 51% female representation at the director level and above. Additionally, the company hosted its first Global Volunteer Day, with employees contributing over 2,000 hours to nonprofit organizations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Women on Board
Women in Management
Employees